L322-0095 Screening compound: N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-(3-fluorophenyl)acetamide

L322-0095 Screening compound: N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-(3-fluorophenyl)acetamide
L322-0095 Screening compound: N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-(3-fluorophenyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L322-0095
N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-(3-fluorophenyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L322-0095

Molecular Formula

C23H26FN3O4S (C23 H26 FN3 O4 S)

Compound Name

N-[6-(cyclohexanesulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-2-(3-fluorophenyl)acetamide

IUPAC name

N-[6-(cyclohexanesulfonyl)-13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]-2-(3-fluorophenyl)acetamide

SMILES

CN(c(c(N1C)c2)cc(NC(Cc3cc(F)ccc3)=O)c2S(C2CCCCC2)(=O)=O)C1=O

InChI

InChI=1S/C23H26FN3O4S/c1-26-19-13-18(25-22(28)12-15-7-6-8-16(24)11-15)21(14-20(19)27(2)23(26)29)32(30,31)17-9-4-3-5-10-17/h6-8,11,13-14,17H,3-5,9-10,12H2,1-2H3,(H,25,28)

InChI Key

HEEXPRFRBHUHJF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244833

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.812

Distribution Coefficient, logD

3.809

Water Solubility, LogSw

-3.92

Polar Surface Area

69.796

Acid Dissociation Constant (pKa)

9.59

Base Dissociation Constant (pKb)

-2.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.10

L322-0095 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with L322-0095 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L322-0095?
Check Price and Availability of L322-0095, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L322-0095 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L322-0095
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L322-0095
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L322-0095 available by request